Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease
Identifieur interne : 006566 ( Main/Merge ); précédent : 006565; suivant : 006567Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease
Auteurs : Pablo Martínez-Martín [Espagne] ; Francesc Valldeoriola [Espagne] ; Eduardo Tolosa [Espagne] ; Manuela Pilleri [Espagne] ; José Luis Molinuevo [Espagne] ; Jordi Rumià [Espagne] ; Enric Ferrer [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-03.
English descriptors
Abstract
We examined the impact of the subthalamic nuclei (STN) deep brain stimulation (DBS) on the health‐related quality of life (QoL) of patients with advanced Parkinson's disease (PD). Seventeen consecutive patients with refractory motor fluctuations and dyskinesia were included in the study (mean age, 60.9 ± 7.7 years [range, 43–74 years]; disease duration, 16.4 ± 8.5 years [range, 7–38 years]; mean off‐medication Hoehn and Yahr stage, 4.23 ± 0.66 [range, 2.5–5]). Each patient's assessment was carried out using common rating scales, following the Core Assessment Program for Intracerebral Transplantation (CAPIT) protocol. Dyskinesia and emotional state were evaluated through the Abnormal Involuntary Movement Scale (AIMS) and the Hospital Anxiety and Depression Scale (HAD). QoL was assessed by means of the Parkinson's Disease Questionnaire Spanish version (PDQ‐39). Significant benefit was obtained in the motor manifestations and complications of disease, as well as in the functional state and mood (P < 0.001). Some QoL dimensions (mobility and activities of daily living) and the PDQ‐39 Summary Index (PDQ‐39SI) showed a significant improvement (P < 0.001). Benefit was modest (P < 0.05) for three other domains (emotional well‐being, stigma, bodily discomfort) and nil for the rest. There was no correlation between the change obtained in the QoL (PDQ‐39SI) and in the other variables. As measured by the PDQ‐39, STN‐DBS significantly improves important aspects of QoL in patients with advanced PD. © 2002 Movement Disorder Society.
Url:
DOI: 10.1002/mds.10044
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000E24
- to stream Istex, to step Curation: 000E24
- to stream Istex, to step Checkpoint: 002E52
Links to Exploration step
ISTEX:880A47F1D9CBD9721DF6997A37B1024B25A41954Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease</title>
<author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martínez-Martín">Pablo Martínez-Martín</name>
</author>
<author><name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
</author>
<author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
</author>
<author><name sortKey="Pilleri, Manuela" sort="Pilleri, Manuela" uniqKey="Pilleri M" first="Manuela" last="Pilleri">Manuela Pilleri</name>
</author>
<author><name sortKey="Molinuevo, Jose Luis" sort="Molinuevo, Jose Luis" uniqKey="Molinuevo J" first="José Luis" last="Molinuevo">José Luis Molinuevo</name>
</author>
<author><name sortKey="Rumia, Jordi" sort="Rumia, Jordi" uniqKey="Rumia J" first="Jordi" last="Rumià">Jordi Rumià</name>
</author>
<author><name sortKey="Ferrer, Enric" sort="Ferrer, Enric" uniqKey="Ferrer E" first="Enric" last="Ferrer">Enric Ferrer</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:880A47F1D9CBD9721DF6997A37B1024B25A41954</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/mds.10044</idno>
<idno type="url">https://api.istex.fr/document/880A47F1D9CBD9721DF6997A37B1024B25A41954/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E24</idno>
<idno type="wicri:Area/Istex/Curation">000E24</idno>
<idno type="wicri:Area/Istex/Checkpoint">002E52</idno>
<idno type="wicri:doubleKey">0885-3185:2002:Martinez Artin P:bilateral:subthalamic:nucleus</idno>
<idno type="wicri:Area/Main/Merge">006566</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease</title>
<author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martínez-Martín">Pablo Martínez-Martín</name>
<affiliation wicri:level="3"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Applied Epidemiology, National Center of Epidemiology, I.S. Carlos III, Madrid</wicri:regionArea>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Valldeoriola, Francesc" sort="Valldeoriola, Francesc" uniqKey="Valldeoriola F" first="Francesc" last="Valldeoriola">Francesc Valldeoriola</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Malalties del Sistema Nerviós, Hospital Clínic, Universitat de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Malalties del Sistema Nerviós, Hospital Clínic, Universitat de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pilleri, Manuela" sort="Pilleri, Manuela" uniqKey="Pilleri M" first="Manuela" last="Pilleri">Manuela Pilleri</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Malalties del Sistema Nerviós, Hospital Clínic, Universitat de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Molinuevo, Jose Luis" sort="Molinuevo, Jose Luis" uniqKey="Molinuevo J" first="José Luis" last="Molinuevo">José Luis Molinuevo</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurology, Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Malalties del Sistema Nerviós, Hospital Clínic, Universitat de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rumia, Jordi" sort="Rumia, Jordi" uniqKey="Rumia J" first="Jordi" last="Rumià">Jordi Rumià</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurosurgery, Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Malalties del Sistema Nerviós, Hospital Clínic, Universitat de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat de Barcelona</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ferrer, Enric" sort="Ferrer, Enric" uniqKey="Ferrer E" first="Enric" last="Ferrer">Enric Ferrer</name>
<affiliation wicri:level="1"><country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Neurosurgery, Parkinson's Disease and Movement Disorders Unit, Institut Clínic de Malalties del Sistema Nerviós, Hospital Clínic, Universitat de Barcelona</wicri:regionArea>
<wicri:noRegion>Universitat de Barcelona</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-03">2002-03</date>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="372">372</biblScope>
<biblScope unit="page" to="377">377</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">880A47F1D9CBD9721DF6997A37B1024B25A41954</idno>
<idno type="DOI">10.1002/mds.10044</idno>
<idno type="ArticleID">MDS10044</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>PDQ‐39</term>
<term>Parkinson's disease</term>
<term>quality of life</term>
<term>subthalamic stimulation</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We examined the impact of the subthalamic nuclei (STN) deep brain stimulation (DBS) on the health‐related quality of life (QoL) of patients with advanced Parkinson's disease (PD). Seventeen consecutive patients with refractory motor fluctuations and dyskinesia were included in the study (mean age, 60.9 ± 7.7 years [range, 43–74 years]; disease duration, 16.4 ± 8.5 years [range, 7–38 years]; mean off‐medication Hoehn and Yahr stage, 4.23 ± 0.66 [range, 2.5–5]). Each patient's assessment was carried out using common rating scales, following the Core Assessment Program for Intracerebral Transplantation (CAPIT) protocol. Dyskinesia and emotional state were evaluated through the Abnormal Involuntary Movement Scale (AIMS) and the Hospital Anxiety and Depression Scale (HAD). QoL was assessed by means of the Parkinson's Disease Questionnaire Spanish version (PDQ‐39). Significant benefit was obtained in the motor manifestations and complications of disease, as well as in the functional state and mood (P < 0.001). Some QoL dimensions (mobility and activities of daily living) and the PDQ‐39 Summary Index (PDQ‐39SI) showed a significant improvement (P < 0.001). Benefit was modest (P < 0.05) for three other domains (emotional well‐being, stigma, bodily discomfort) and nil for the rest. There was no correlation between the change obtained in the QoL (PDQ‐39SI) and in the other variables. As measured by the PDQ‐39, STN‐DBS significantly improves important aspects of QoL in patients with advanced PD. © 2002 Movement Disorder Society.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006566 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 006566 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:880A47F1D9CBD9721DF6997A37B1024B25A41954 |texte= Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease }}
This area was generated with Dilib version V0.6.23. |